Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not be about the study. Revision: v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T10:47:47.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The funding-lapse operating-status notice on the page was removed, eliminating the informational banner about potential processing delays. This change does not affect the study details or accessibility of the trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T06:57:38.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Taiwan site entry updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704'. This is a naming correction in the locations list to reflect the correct city name.
    Difference
    0.0%
    Check dated 2025-11-11T02:45:41.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The study locations list has been expanded across many countries, and the last update date on the record has been refreshed to reflect updated information.
    Difference
    0.2%
    Check dated 2025-11-03T20:58:13.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Major update: adds a government funding/operating status notice and updates version to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:57:37.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    - Added Revision: v3.1.0. - Removed topics: MedlinePlus related topics: Drug Safety; Counterfeit Drugs; Pharmaceutical Preparations; Substandard Drugs; Revision: v3.0.2.
    Difference
    0.4%
    Check dated 2025-09-29T02:56:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.